Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 3/20 | 0.39 |
| ▸ | CASR | P41180 | 5/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.30 |
| ▸ | CTSD | P07339 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5223471 | 0.80 | ADRB1 (0.38) | ADRB1ADRB2 | |
| Hydrochloric Acid SCHEMBL5217902 | 0.78 | ADRB1 (0.41) | ADRB1ADRB2CTSDBACE1 | |
| SCHEMBL12975966 | 0.74 | ADRA2A (0.41) | — | |
| SCHEMBL5226454 | 0.72 | ALDH1A1 (0.38) | CASR | |
| SCHEMBL13886438 | 0.71 | IDO1 (0.38) | — | |
| SCHEMBL2874304 | 0.68 | TYR (0.44) | ADRB1 | |
| SCHEMBL12834447 | 0.67 | TAAR1 (0.45) | ADRB1CASRADRB2ADRB3 | |
| SCHEMBL2873319 | 0.65 | BCHE (0.33) | — | |
| SCHEMBL13435041 | 0.64 | SLC6A3 (0.38) | — | |
| SCHEMBL13435053 | 0.64 | SLC6A3 (0.41) | ADRB1CTSDBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567488-B1 | HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | GLAXO GROUP LTD (GB) | 2007-02-21 | — | — | EP | disclosed |